Loading…

Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat

Synchronous hippocampal electroencephalographic activity occurring in a frequency range of 3 to12 Hz (i.e., hippocampal theta rhythm) has been associated with mnemonic processes in vivo. However, this link is tenuous and theta rhythm may be secondary to processes that underlie mnemonic function. If...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacology and experimental therapeutics 1999-10, Vol.291 (1), p.99
Main Authors: Kinney, G G, Patino, P, Mermet-Bouvier, Y, Starrett, Jr, J E, Gribkoff, V K
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page 99
container_title The Journal of pharmacology and experimental therapeutics
container_volume 291
creator Kinney, G G
Patino, P
Mermet-Bouvier, Y
Starrett, Jr, J E
Gribkoff, V K
description Synchronous hippocampal electroencephalographic activity occurring in a frequency range of 3 to12 Hz (i.e., hippocampal theta rhythm) has been associated with mnemonic processes in vivo. However, this link is tenuous and theta rhythm may be secondary to processes that underlie mnemonic function. If theta rhythm is associated with mnemonic or cognitive function, cognition-enhancing drugs should enhance theta rhythm regardless of their primary biological target. In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclinical behavioral models and that vary with respect to their primary biological target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg). All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal theta rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak theta frequency in the urethane-anesthetized rat. These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compounds. The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced theta amplitude (both) and frequency (dizocilipine maleate only). These data demonstrate that hippocampal theta rhythm is sensitive to cognition-modulating compounds, suggesting that theta rhythm may be closely associated with cognitive function.
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_10490892</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10490892</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-898d3d9d15f0110f1f4d4492e178a33a51fca93a05538ccb3a9eb2baaddd7b3c3</originalsourceid><addsrcrecordid>eNo1T8tKxDAUzUJxxtFfkPxAIM9ps5TiCwZmo-vhNknbSJvGJF2MX28HdXE4cF5wrtCWUs6JUHu1Qbc5f1LKpNyLG7RhVGpaa75FX83cB1_8HIgLAwTjQ49tWvqMfTDJQXY4Fz8tIxRn8eBjnA1MEUZcBlcAp-Fchgmv0ujLYt1auzh4Sa6se46syJeo_177Ccoduu5gzO7-j3fo4_npvXklh-PLW_N4IJHTqpBa11ZYbZnqKGO0Y520UmruWFWDEKBYZ0ALoEqJ2phWgHYtbwGstVUrjNihh9_duLSTs6eY_ATpfPr_Ln4A8tNYfQ</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat</title><source>Medical Journals</source><creator>Kinney, G G ; Patino, P ; Mermet-Bouvier, Y ; Starrett, Jr, J E ; Gribkoff, V K</creator><creatorcontrib>Kinney, G G ; Patino, P ; Mermet-Bouvier, Y ; Starrett, Jr, J E ; Gribkoff, V K</creatorcontrib><description>Synchronous hippocampal electroencephalographic activity occurring in a frequency range of 3 to12 Hz (i.e., hippocampal theta rhythm) has been associated with mnemonic processes in vivo. However, this link is tenuous and theta rhythm may be secondary to processes that underlie mnemonic function. If theta rhythm is associated with mnemonic or cognitive function, cognition-enhancing drugs should enhance theta rhythm regardless of their primary biological target. In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclinical behavioral models and that vary with respect to their primary biological target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg). All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal theta rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak theta frequency in the urethane-anesthetized rat. These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compounds. The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced theta amplitude (both) and frequency (dizocilipine maleate only). These data demonstrate that hippocampal theta rhythm is sensitive to cognition-modulating compounds, suggesting that theta rhythm may be closely associated with cognitive function.</description><identifier>ISSN: 0022-3565</identifier><identifier>PMID: 10490892</identifier><language>eng</language><publisher>United States</publisher><subject>Anesthesia ; Anesthetics, Intravenous ; Animals ; Hippocampus - drug effects ; Hippocampus - physiology ; Male ; Nootropic Agents - pharmacology ; Rats ; Rats, Long-Evans ; Theta Rhythm - drug effects ; Urethane</subject><ispartof>The Journal of pharmacology and experimental therapeutics, 1999-10, Vol.291 (1), p.99</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10490892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kinney, G G</creatorcontrib><creatorcontrib>Patino, P</creatorcontrib><creatorcontrib>Mermet-Bouvier, Y</creatorcontrib><creatorcontrib>Starrett, Jr, J E</creatorcontrib><creatorcontrib>Gribkoff, V K</creatorcontrib><title>Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat</title><title>The Journal of pharmacology and experimental therapeutics</title><addtitle>J Pharmacol Exp Ther</addtitle><description>Synchronous hippocampal electroencephalographic activity occurring in a frequency range of 3 to12 Hz (i.e., hippocampal theta rhythm) has been associated with mnemonic processes in vivo. However, this link is tenuous and theta rhythm may be secondary to processes that underlie mnemonic function. If theta rhythm is associated with mnemonic or cognitive function, cognition-enhancing drugs should enhance theta rhythm regardless of their primary biological target. In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclinical behavioral models and that vary with respect to their primary biological target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg). All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal theta rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak theta frequency in the urethane-anesthetized rat. These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compounds. The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced theta amplitude (both) and frequency (dizocilipine maleate only). These data demonstrate that hippocampal theta rhythm is sensitive to cognition-modulating compounds, suggesting that theta rhythm may be closely associated with cognitive function.</description><subject>Anesthesia</subject><subject>Anesthetics, Intravenous</subject><subject>Animals</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - physiology</subject><subject>Male</subject><subject>Nootropic Agents - pharmacology</subject><subject>Rats</subject><subject>Rats, Long-Evans</subject><subject>Theta Rhythm - drug effects</subject><subject>Urethane</subject><issn>0022-3565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNo1T8tKxDAUzUJxxtFfkPxAIM9ps5TiCwZmo-vhNknbSJvGJF2MX28HdXE4cF5wrtCWUs6JUHu1Qbc5f1LKpNyLG7RhVGpaa75FX83cB1_8HIgLAwTjQ49tWvqMfTDJQXY4Fz8tIxRn8eBjnA1MEUZcBlcAp-Fchgmv0ujLYt1auzh4Sa6se46syJeo_177Ccoduu5gzO7-j3fo4_npvXklh-PLW_N4IJHTqpBa11ZYbZnqKGO0Y520UmruWFWDEKBYZ0ALoEqJ2phWgHYtbwGstVUrjNihh9_duLSTs6eY_ATpfPr_Ln4A8tNYfQ</recordid><startdate>199910</startdate><enddate>199910</enddate><creator>Kinney, G G</creator><creator>Patino, P</creator><creator>Mermet-Bouvier, Y</creator><creator>Starrett, Jr, J E</creator><creator>Gribkoff, V K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>199910</creationdate><title>Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat</title><author>Kinney, G G ; Patino, P ; Mermet-Bouvier, Y ; Starrett, Jr, J E ; Gribkoff, V K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-898d3d9d15f0110f1f4d4492e178a33a51fca93a05538ccb3a9eb2baaddd7b3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anesthesia</topic><topic>Anesthetics, Intravenous</topic><topic>Animals</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - physiology</topic><topic>Male</topic><topic>Nootropic Agents - pharmacology</topic><topic>Rats</topic><topic>Rats, Long-Evans</topic><topic>Theta Rhythm - drug effects</topic><topic>Urethane</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kinney, G G</creatorcontrib><creatorcontrib>Patino, P</creatorcontrib><creatorcontrib>Mermet-Bouvier, Y</creatorcontrib><creatorcontrib>Starrett, Jr, J E</creatorcontrib><creatorcontrib>Gribkoff, V K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kinney, G G</au><au>Patino, P</au><au>Mermet-Bouvier, Y</au><au>Starrett, Jr, J E</au><au>Gribkoff, V K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat</atitle><jtitle>The Journal of pharmacology and experimental therapeutics</jtitle><addtitle>J Pharmacol Exp Ther</addtitle><date>1999-10</date><risdate>1999</risdate><volume>291</volume><issue>1</issue><spage>99</spage><pages>99-</pages><issn>0022-3565</issn><abstract>Synchronous hippocampal electroencephalographic activity occurring in a frequency range of 3 to12 Hz (i.e., hippocampal theta rhythm) has been associated with mnemonic processes in vivo. However, this link is tenuous and theta rhythm may be secondary to processes that underlie mnemonic function. If theta rhythm is associated with mnemonic or cognitive function, cognition-enhancing drugs should enhance theta rhythm regardless of their primary biological target. In the current study, we evaluated several drugs that were shown to have cognition-enhancing properties in preclinical behavioral models and that vary with respect to their primary biological target: 1) the nootropic piracetam (250 and 500 mg/kg); 2) the small-conductance calcium-activated potassium-channel blocker apamin (0.1 and 0.4 mg/kg); and 3) the acetylcholinesterase inhibitor donepezil (0.1-10.0 mg/kg). All of the cognition-enhancing drugs produced dose-dependent increases in hippocampal theta rhythm amplitude elicited by stimulation of the brainstem reticular formation at doses that did not affect peak theta frequency in the urethane-anesthetized rat. These increases were reversed by the muscarinic receptor antagonist scopolamine, suggesting a common final cholinergic action of these compounds. The use-dependent N-methyl-D-aspartate antagonist dizocilipine maleate and scopolamine reduced theta amplitude (both) and frequency (dizocilipine maleate only). These data demonstrate that hippocampal theta rhythm is sensitive to cognition-modulating compounds, suggesting that theta rhythm may be closely associated with cognitive function.</abstract><cop>United States</cop><pmid>10490892</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0022-3565
ispartof The Journal of pharmacology and experimental therapeutics, 1999-10, Vol.291 (1), p.99
issn 0022-3565
language eng
recordid cdi_pubmed_primary_10490892
source Medical Journals
subjects Anesthesia
Anesthetics, Intravenous
Animals
Hippocampus - drug effects
Hippocampus - physiology
Male
Nootropic Agents - pharmacology
Rats
Rats, Long-Evans
Theta Rhythm - drug effects
Urethane
title Cognition-enhancing drugs increase stimulated hippocampal theta rhythm amplitude in the urethane-anesthetized rat
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A06%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognition-enhancing%20drugs%20increase%20stimulated%20hippocampal%20theta%20rhythm%20amplitude%20in%20the%20urethane-anesthetized%20rat&rft.jtitle=The%20Journal%20of%20pharmacology%20and%20experimental%20therapeutics&rft.au=Kinney,%20G%20G&rft.date=1999-10&rft.volume=291&rft.issue=1&rft.spage=99&rft.pages=99-&rft.issn=0022-3565&rft_id=info:doi/&rft_dat=%3Cpubmed%3E10490892%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p207t-898d3d9d15f0110f1f4d4492e178a33a51fca93a05538ccb3a9eb2baaddd7b3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/10490892&rfr_iscdi=true